These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

568 related items for PubMed ID: 29410368

  • 1. Surveillance of tigecycline activity tested against clinical isolates from a global (North America, Europe, Latin America and Asia-Pacific) collection (2016).
    Pfaller MA, Huband MD, Streit JM, Flamm RK, Sader HS.
    Int J Antimicrob Agents; 2018 Jun; 51(6):848-853. PubMed ID: 29410368
    [Abstract] [Full Text] [Related]

  • 2. Tigecycline activity tested against antimicrobial resistant surveillance subsets of clinical bacteria collected worldwide (2011).
    Sader HS, Flamm RK, Jones RN.
    Diagn Microbiol Infect Dis; 2013 Jun; 76(2):217-21. PubMed ID: 23522845
    [Abstract] [Full Text] [Related]

  • 3. Antimicrobial susceptibility among gram-positive and gram-negative blood-borne pathogens collected between 2012-2016 as part of the Tigecycline Evaluation and Surveillance Trial.
    Zhang Z, Chen M, Yu Y, Pan S, Liu Y.
    Antimicrob Resist Infect Control; 2018 Jun; 7():152. PubMed ID: 30564308
    [Abstract] [Full Text] [Related]

  • 4. In vitro activity of tigecycline and comparators (2014-2016) among key WHO 'priority pathogens' and longitudinal assessment (2004-2016) of antimicrobial resistance: a report from the T.E.S.T. study.
    Seifert H, Blondeau J, Dowzicky MJ.
    Int J Antimicrob Agents; 2018 Oct; 52(4):474-484. PubMed ID: 30012439
    [Abstract] [Full Text] [Related]

  • 5. Antimicrobial susceptibility among Gram-positive and Gram-negative organisms collected from the Latin American region between 2004 and 2015 as part of the Tigecycline Evaluation and Surveillance Trial.
    Vega S, Dowzicky MJ.
    Ann Clin Microbiol Antimicrob; 2017 Jul 12; 16(1):50. PubMed ID: 28701170
    [Abstract] [Full Text] [Related]

  • 6. Surveillance of Omadacycline Activity against Clinical Isolates from a Global Collection (North America, Europe, Latin America, Asia-Western Pacific), 2010-2011.
    Pfaller MA, Huband MD, Rhomberg PR, Flamm RK.
    Antimicrob Agents Chemother; 2017 May 12; 61(5):. PubMed ID: 28223386
    [Abstract] [Full Text] [Related]

  • 7. Update on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the United States: results from the Tigecycline Evaluation and Surveillance Trial (TEST) 2005 to 2007.
    Dowzicky MJ, Park CH.
    Clin Ther; 2008 Nov 12; 30(11):2040-50. PubMed ID: 19108792
    [Abstract] [Full Text] [Related]

  • 8. Antimicrobial activity of ceftaroline and comparator agents tested against bacterial isolates causing skin and soft tissue infections and community-acquired respiratory tract infections isolated from the Asia-Pacific region and South Africa (2010).
    Sader HS, Flamm RK, Jones RN.
    Diagn Microbiol Infect Dis; 2013 May 12; 76(1):61-8. PubMed ID: 23535208
    [Abstract] [Full Text] [Related]

  • 9. Tigecycline antimicrobial activity tested against clinical bacteria from Latin American medical centres: results from SENTRY Antimicrobial Surveillance Program (2011-2014).
    Sader HS, Castanheira M, Farrell DJ, Flamm RK, Mendes RE, Jones RN.
    Int J Antimicrob Agents; 2016 Aug 12; 48(2):144-50. PubMed ID: 27291285
    [Abstract] [Full Text] [Related]

  • 10. Susceptibility to tigecycline and linezolid among gram-positive isolates collected in the United States as part of the tigecycline evaluation and surveillance trial (TEST) between 2004 and 2009.
    Dowzicky MJ.
    Clin Ther; 2011 Dec 12; 33(12):1964-73. PubMed ID: 22078154
    [Abstract] [Full Text] [Related]

  • 11. In Vitro Activity of Plazomicin against Gram-Negative and Gram-Positive Isolates Collected from U.S. Hospitals and Comparative Activities of Aminoglycosides against Carbapenem-Resistant Enterobacteriaceae and Isolates Carrying Carbapenemase Genes.
    Castanheira M, Davis AP, Mendes RE, Serio AW, Krause KM, Flamm RK.
    Antimicrob Agents Chemother; 2018 Aug 12; 62(8):. PubMed ID: 29866862
    [Abstract] [Full Text] [Related]

  • 12. Antimicrobial susceptibility among gram-negative isolates collected from intensive care units in North America, Europe, the Asia-Pacific Rim, Latin America, the Middle East, and Africa between 2004 and 2009 as part of the Tigecycline Evaluation and Surveillance Trial.
    Bertrand X, Dowzicky MJ.
    Clin Ther; 2012 Jan 12; 34(1):124-37. PubMed ID: 22154196
    [Abstract] [Full Text] [Related]

  • 13. In vitro activity of tigecycline, a new glycylcycline, tested against 1,326 clinical bacterial strains isolated from Latin America.
    Gales AC, Jones RN, Andrade SS, Pereira AS, Sader HS.
    Braz J Infect Dis; 2005 Oct 12; 9(5):348-56. PubMed ID: 16410885
    [Abstract] [Full Text] [Related]

  • 14. Surveillance of omadacycline activity tested against clinical isolates from the United States and Europe: Results from the SENTRY Antimicrobial Surveillance Programme, 2017.
    Huband MD, Pfaller MA, Shortridge D, Flamm RK.
    J Glob Antimicrob Resist; 2019 Dec 12; 19():56-63. PubMed ID: 30825698
    [Abstract] [Full Text] [Related]

  • 15. Antimicrobial Activity of Omadacycline Tested against Clinical Bacterial Isolates from Hospitals in Mainland China, Hong Kong, and Taiwan: Results from the SENTRY Antimicrobial Surveillance Program (2013 to 2016).
    Carvalhaes CG, Huband MD, Reinhart HH, Flamm RK, Sader HS.
    Antimicrob Agents Chemother; 2019 Mar 12; 63(3):. PubMed ID: 30617092
    [Abstract] [Full Text] [Related]

  • 16. Trends in the susceptibility of clinically important resistant bacteria to tigecycline: results from the Tigecycline In Vitro Surveillance in Taiwan study, 2006 to 2010.
    Chen YH, Lu PL, Huang CH, Liao CH, Lu CT, Chuang YC, Tsao SM, Chen YS, Liu YC, Chen WY, Jang TN, Lin HC, Chen CM, Shi ZY, Pan SC, Yang JL, Kung HC, Liu CE, Cheng YJ, Liu JW, Sun W, Wang LS, Ko WC, Yu KW, Chiang PC, Lee MH, Lee CM, Hsu GJ, Hsueh PR.
    Antimicrob Agents Chemother; 2012 Mar 12; 56(3):1452-7. PubMed ID: 22203598
    [Abstract] [Full Text] [Related]

  • 17. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
    Sader HS, Jones RN, Dowzicky MJ, Fritsche TR.
    Diagn Microbiol Infect Dis; 2005 Jul 12; 52(3):203-8. PubMed ID: 16105565
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.